Business Context and Reporting Period
This Form 8-K, dated July 20, 2026, reports a material event for Tempus AI, Inc. (Nasdaq: TEM). The filing announces the execution of an Agreement and Plan of Merger with Personalis, Inc.. Under the terms of the agreement, Tempus will acquire Personalis through a two-step merger process, resulting in Personalis becoming a direct, wholly-owned subsidiary of Tempus.
Key Financial Metrics
This filing is a current report regarding a corporate transaction and does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data for Tempus AI or Personalis. The document references historical financial data contained in the companies' respective 2025 Form 10-K filings but does not reproduce those figures.
Material Changes and Transaction Structure
- Merger Agreement: Tempus and Personalis entered into a definitive agreement on July 20, 2026.
- Structure:
- First Merger: Aviary Development, Inc. (Merger Sub I) will merge with and into Personalis, with Personalis surviving as a Tempus subsidiary.
- Second Merger: Immediately following the First Merger, Personalis will merge with and into Toucan Development, LLC (Merger Sub II), with Merger Sub II surviving as a Tempus subsidiary.
- Termination Right: Personalis retains the right to terminate the Merger Agreement if the market price of Tempus Class A common stock falls below $46.00 prior to closing.
Guidance, Outlook, and Risks
The filing includes extensive forward-looking statements regarding the proposed transaction. Management notes that the transaction is subject to numerous conditions and risks, including:
- Regulatory Approvals: The transaction requires governmental and regulatory approvals, which may be delayed, conditioned, or denied.
- Stockholder Approval: The agreement is contingent upon adoption by Personalis stockholders.
- Operational Risks: Potential disruption to management time, retention of key personnel, and integration challenges that could prevent the realization of anticipated synergies.
- Market Risks: Adverse effects on stock prices and the risk that third-party payers may not provide adequate reimbursement for the combined company's offerings.
- AI and Data Risks: Operational, legal, and reputational risks associated with the use of artificial intelligence in the combined company's products.
Tempus intends to file a registration statement on Form S-4 and a Schedule 13E-3 with the SEC, which will contain the definitive proxy statement/prospectus.
Investor Verification Checklist
- Verify the definitive proxy statement/prospectus (Form S-4) once filed to review the specific consideration offered to Personalis shareholders and the exact terms of the merger.
- Monitor the market price of Tempus Class A common stock to assess the risk of the transaction being terminated if the price drops below $46.00.
- Review the 2025 Form 10-K filings for both Tempus and Personalis to understand the historical financial performance and risk factors of each entity prior to the merger.
- Track the status of regulatory approvals and stockholder votes required to close the transaction.
- Examine the joint press release (Exhibit 99.1) for any additional strategic rationale or management commentary not detailed in the 8-K text.